Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors : From antigen choice to clinical implementation
Immunotherapy with T cells expressing chimeric antigen receptors (CAR) is being evaluated as a potential treatment for B-cell neoplasms. In recent clinical trials it has shown promising results. As the number of potential candidate antigens expands, the choice of suitable target antigens becomes mor...
Main Authors: | Mohamed-Rachid Boulasse, Ahmed Galal |
---|---|
Format: | Article |
Language: | English |
Published: |
Sultan Qaboos University
2012-08-01
|
Series: | Sultan Qaboos University Medical Journal |
Subjects: | |
Online Access: | https://journals.squ.edu.om/index.php/squmj/article/view/1687 |
Similar Items
-
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01) -
Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
by: Zhang Xu, et al.
Published: (2019-07-01) -
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
by: Ahmet Yilmaz, et al.
Published: (2020-12-01) -
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01) -
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
by: Giuseppe Fanciulli, et al.
Published: (2022-08-01)